Abstract
The estrogen receptor α (ERα) is implicated in the development of breast cancer. The immunophilins, cyclophilin 40 (CyP40) and FKBP52, are associated with ERα and other steroid receptors in mutually exclusive heterocomplexes and may differentially modulate receptor activity. Since previous studies have not assessed the levels of these immunophilins in breast cancer, we examined 10 breast cancer cell lines for mRNA and protein expression of CyP40 and FKBP52 and for amplification of the CyP40 gene. In addition, 26 breast carcinomas, including seven with matched normal breast tissue, were examined for mRNA expression of both immunophilins. CyP40 and FKBP52 were ubiquitously expressed in breast cancer cell lines, but there were significant differences in their pattern of expression. FKBP52 protein levels were generally an order of magnitude greater than those for CyP40. FKBP52 mRNA expression correlated strongly with protein expression and was significantly higher in ERα-positive compared with ERα-negative cell lines. However, CyP40 mRNA expression did not correlate with protein expression, nor did expression of this immunophilin correlate with ERα status. Relatively high expression of CyP40 in one cell line (BT-20) could be attributed to amplification of the CyP40 gene. Both immunophilins were also ubiquitously expressed in breast carcinomas, and we demonstrate for the first time that both CyP40 and FKBP52 mRNA are overexpressed in breast tumors compared to matched normal breast controls. The overexpression of CyP40 and FKBP52, coupled with relative differences in their expression in tumors, may have important functional implications for ERα and other steroid receptors in breast cancer.
Similar content being viewed by others
References
Ciocca DR, Fanelli MA: Estrogen receptors and cell proliferation in breast cancer. TEM 8: 313–321, 1997
McGuire WL, Chamness GC, Fuqua SAW: Estrogen receptor variants in clinical breast cancer. Mol Endocrinol 5: 1571–1577, 1991
Henderson BE, Ross RK, Pike MC: Toward the primary prevention of cancer. Science 254: 1131–1138, 1991
Bocchinfuso WP, Couse JF, Hively WP, Varmus HE, Korach KS: Hormonal signaling pathways in mammary glands of ERKO/Wnt-1 mice (Abstract 0R40-4). In: Proceedings of the 80th Annual Meeting of The Endocrine Society, New Orleans, Louisiana, 1998
Pratt WB, Toft DO: Steroid receptor interactions with heat shock protein and immunophilin chaperones. Endocrin Revs 18: 306–360, 1997
Gething M-J, Sambrook J: Protein folding in the cell. Nature 355: 33–45, 1992
Fruman DA, Burakoff SJ, Bierer BE: Immunophilins in protein folding and immunosuppression. FASEB J 8: 391–400, 1994
Bose S, Weikl T, Bügl H, Buchner J: Chaperone function of hsp90-associated proteins. Science 274: 1715–1717, 1996
Freeman BC, Toft DO, Morimoto RI: Molecular chaperone machines: chaperone activities of the cyclophilin cyp-40 and the steroid aporeceptor-associated protein p23. Science 274: 1718–1720, 1996
Sanchez ER: Hsp56: a novel heat shock protein associated with untransformed steroid receptor complexes. J Biol Chem 265: 22067–22070, 1990
Weisman R, Creanor J, Fantes P: A multicopy suppressor of a cell cycle defect in S. pombe encodes a heat shock-inducible 40 kDa cyclophilin-like protein EMBO J 15: 447–456, 1996
Warth R, Briand P-A, Picard D: Functional analysis of the yeast 40 kDa cyclophilin cyp40 and its role for viability and steroid receptor regulation. Biol Chem 378: 381–391, 1997
Duina AA, Chang H-CJ, Marsh JA, Lindquist S, Gaber RF: A cyclophilin function in hsp90-dependent signal transduction. Science 274: 1713–1715, 1996
Czar MJ, Lyons RH, Welsh MJ, Renoir J-M, Pratt WB: Evidence that the FK506-binding immunophilin heat shock protein 56 is required for trafficking of the glucocorticoid receptor from the cytoplasm to the nucleus. Mol Endocrinol 9: 1549–1560, 1995
Owens-Grillo JK, Czar MJ, Hutchison KA, Hoffmann K, Perdew GH, Pratt WB: A model of protein targeting mediated by immunophilins and other proteins that bind to hsp90 via tetratricopeptide repeat domains. J Biol Chem 271: 13468–13475, 1996
Reynolds PD, Ruan Y, Smith DF, Scammell JG: Glucocorticoid resistance in the squirrel monkey is associated with overexpression of the immunophilin FKBP51. J Clin Endocrin Metab 84: 663–669, 1999
Duina AA, Kalton HM, Gaber RF: Requirement for hsp90 and a cyp-40-type cyclophilin in negative regulation of the heat shock response. J Biol Chem 273: 18974–18978, 1998
Doucet-Brutin S, Renoir M, LeGallic L, Vincent S, Marty L, Fort P: Growth regulated expression of FKBP-59 immunophilin in normal and transformed fibroblastic cells. Exp Cell Res 220: 152–160, 1995
Perrot-Applanat M, Cibert C, Geraud G, Renoir J-M, Baulieu E-E: The 59 kDa FK506-binding protein, a 90 kDa heat shock protein binding immunophilin (FKBP59-HBI), is associated with the nucleus, the cytoskeleton and mitotic apparatus. J Cell Sci 108: 2037–2051, 1995
Yeh W-C, Li T-K, Bierer BE, McKnight SL: Identification and characterization of an immunophilin expressed during the clonal expansion phase of adipocyte differentiation. Proc NatI Acad Sci USA 92: 11081–11085, 1995
Musgrove EA, Hamilton JA, Lee CSL, Sweeney KJE, Watts CKW, Sutherland RL: Growth factor, steroid, and steroid antagonist regulation of cyclin gene expression associated with changes in T-47D human breast cancer cell cycle progression. Mol Cell Biol 13: 3577–3587, 1993
Elston CW, Ellis IO: Pathological prognostic factors in breast cancer. I The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology 19: 403–410, 1991
Sambrook J, Fritsch EF, Maniatis T: Molecular Cloning: A Laboratory Manual, 2nd ed. Cold Spring Harbor Laboratory, New York, 1989
Ratajczak T, Mark PJ, Martin RF, Minchin RF: Cyclosporin A potentiates estradiol-induced expression of the cathepsin D gene in MCF7 breast cancer cells. Biochem Biophys Res Commun 220: 208–212, 1996
Ratajczak T, Carrello A, Mark PJ, Warner BJ, Simpson RJ, Moritz RL, House AK: The cyclophilin component of the unactivated estrogen receptor contains a tetratricopeptide repeat domain and shares identity with p59 (FKBP59). J Biol Chem 268: 13187–13192, 1993
Peattie DA, Harding MW, Fleming MA, DeCenzo MT, Lippke JA, Livingston DJ, Benasutti M: Expression and characterization of human FKBP52, an immunophilin that associates with the 90-kDa heat shock protein and is a component of steroid receptor complexes. Proc Natl Acad Sci USA 89: 10974–10978, 1992
Katz RA, Erlanger BF, Guntaka RV: Evidence for extensive methylation of ribosomal RNA genes in a rat XC cell line. Biochim Biophys Acta 739: 258–264, 1983
Fawell SE, White R, Hoare S, Sydenham M, Page M, Parker MG: Inhibition of estrogen receptor-DNA binding by the 'pure' antiestrogen ICI 164,384 appears to be mediated by impaired receptor dimerization. Proc Natl Acad Sci USA 87: 6883–6887, 1990
Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248–254, 1976
Ratajczak T, Carrello A, Minchin RF: Biochemical and calmodulin binding properties of estrogen receptor binding cyclophilin expressed in Escherichia coli. Biochem Biophys Res Commun 209: 117–125, 1995
Kieffer LJ, Seng TW, Li W, Osterman DG, Handschumacher RE, Bayney RM: Cyclophilin-40, a protein with homology to the p59 component of the steroid receptor complex. J Biol Chem 268: 12303–12310, 1993
Tai P-KK, Maeda Y, Nakao K, Wakim NG, Duhring JL, Faber LE: A 59-kilodalton protein associated with progestin, estrogen, androgen, and glucocorticoid receptors. Biochemistry 25: 5269–5275, 1986
Chambraud B, Rouviere-Fourmy N, Radanyi C, Hsiao K, Peattie DA, Livingston DJ, Baulieu EE: Overexpression of p59-HBI (FKBP59), full length and domains, and characterization of PPIase activity. Biochem Biophys Res Commun 196: 160–166, 1993
Masiakowski P, Breathnach R, Bloch J, Gannon F, Krust A, Chambon P: Cloning of cDNA sequences of hormoneregulated genes from theMCF-7 human breast cancer cell line. Nucl Acids Res 10: 7895–7903, 1982
Laborda J: 36B4 cDNA used as an estradiol-independent mRNA control is the cDNA for human acidic ribosomal phosphoprotein PO. Nucl Acids Res 19: 3998, 1991
Kulski JK, Howard MJ, Pixley EC: DNA sequences of human papillomavirus types 11, 16 or 18 in invasive cervical carcinoma of Western Australian women. Immunol Cell Biol 65: 77–84, 1987
Ng SY, Gunning P, Eddy R, Ponte P. Leavitt J, Shows T, Kedes L: Evolution of the functional human beta-actin gene and its multi-pseudogene family: conservation of noncoding regions and chromosomal dispersion of pseudogenes. Mol Cell Biol 5: 2720–2732, 1985
Yokoi H, Shimizu Y, Anazawa H, Lefebvre CA, Korneluk RG, Ikeda J-E: The structure and complete nucleotide sequence of the human cyclophilin 40 (PPID) gene. Genomics 35: 448–455, 1996
Nair SC, Rimerman RA, Toran EJ, Chen S, Prapapanich V, Butts RN, Smith DF: Molecular cloning of human FKBP51 and comparisons of immunophilin interactions with hsp90 and progesterone receptor. Mol Cell Biol 17: 594–603, 1997
Nurse P: Universal control mechanism regulating onset of M-phase. Nature 344: 503–508, 1990
Karnik PS, Kulkarni S, Liu X-P, Budd GT, Bukowski RM: Estrogen receptor mutations in tamoxifen-resistant breast cancer. Cancer Res 54: 349–353, 1994
Gress TM, Müller-Pillasch F, Weber C, Lerch MM, Friess H, Buchler M, Beger HG, Adler G: Differential expression of heat shock proteins in pancreatic carcinoma. Cancer Res 54: 547–551, 1994
Conroy SE, Latchman DS: Do heat shock proteins have a role in breast cancer? Br J Cancer 74: 717–721, 1996
Yano M, Naito Z, Tanaka S, Asano G: Expression and roles of heat shock proteins in human breast cancer. Jap J Cancer Res 87: 908–915, 1996
Morimoto RI: Cells in stress: transcriptional activation of heat shock genes. Science 259: 1409–1410, 1993
Jäättelä M, Wissing D, Bauer PA, Li GC: Major heat shock protein hsp70 protects tumor cells from tumor necrosis factor cytotoxicity. EMBO J 11: 3507–3512, 1992
Ciocca DR. Oesterreich S, Chamness GC, McGuire WL, Fuqua SAW: Biological and clinical implications of heat shock protein 27000 (hsp27): a review. J Natl Cancer Inst 85: 1558–1570, 1993
Ciocca DR, Clark GM, Tandon AK, Fuqua SAW, Welch WJ, McGuire WL: Heat shock protein hsp70 in patients with axillary lymph node-negative breast cancer: prognostic implications. J Natl Cancer Inst 85: 570–574, 1993
Buchner J: Hsp90 & Co. - a holding for folding. TIBS 24: 136–141, 1999
Segnitz B, Gehring U: Subunit structure of the nonactivated human estrogen receptor. Proc Natl Acad Sci USA 92: 2179–2183, 1995
Baughman G, Wiederrecht GJ, Chang F, Martin MM, Bourgeois S: Tissue distribution and abundance of human FKBP5I, an FK506-binding protein that can mediate calcineurin inhibition. Biochem Biophys Res Commun 232: 437–443, 1997
Enmark E, Pelto-Huikko M, Grandien K, Lagercrantz S, Lagercrantz J, Fried G, Nordenskjöld M, Gustafsson J-Å: Human estrogen receptor b-gene structure, chromosomal localization, and expression pattern. J Clin Endocrin Metab 82: 4258–4265, 1997
Hall RE, Lee CSL, Alexander IE, Shine J, Clarke CL, Sutherland R: Steroid hormone receptor gene expression in human breast cancer cells: inverse relationship between estrogen and glucocorticoid receptor messenger RNA levels. Int J Cancer 46: 1081–1087, 1990
Barent RL, Nair SC, Carr DC, Ruan Y, Rimerman RA, Fulton F, Zhang Y, Smith DF: Analysis of FKBP51/FKBP52 chimeras and mutants for hsp90 binding and association with progesterone receptor complexes. Mol Endocrinol 12: 342–354, 1998
Kay PH, Jacobsen PF, Taylor J, Spagnolo D: The significance of DNA methylation in cancer. Adv Anat Path 2: 353–361, 1995
Kallioniemi A, Kallioniemi O-P, Piper J, Tanner M, Stokke T, Chen L, Smith HS, Pinkel D, Gray JW, Waldman FM: Detection and mapping of amplified DNA sequences in breast cancer by comparative genomic hybridization. Proc Natl Acad Sci USA 91: 2156–2160, 1994
Ratajczak T, Woollatt E, Kumar P, Ward BK, Minchin RF, Baker E: Cyclophilin 40 (PPID) gene. Map position 4q31.3. Chromosome Res 5: 151, 1997
Rights and permissions
About this article
Cite this article
Ward, B.K., Mark, P.J., Ingram, D.M. et al. Expression of the estrogen receptor-associated immunophilins, cyclophilin 40 and FKBP52, in breast cancer. Breast Cancer Res Treat 58, 265–278 (1999). https://doi.org/10.1023/A:1006390804515
Issue Date:
DOI: https://doi.org/10.1023/A:1006390804515